16-80: Non-invasive testing cannot identify a typical substrate for life-threatening re-entry VTs in athletes
Jeroen Venlet(Leiden University Medical Center), Katja Zeppenfeld(Leiden University Medical Center), Sebastiaan R.D. Piers(Leiden University Medical Center), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), Marta Riva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Martin J. Schalij(Leiden University Medical Center), Yoshihisa Naruse(Hamamatsu University School of Medicine)
Cited by 0
Related Papers
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Journal of Cardio-Thoracic Surgery|2016|1.4k
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
|Haematologica|2009|309